Access To Medicines During The Covid-19 Pandemic. The Role Of The Medicines Patent Pool

Access to medicines during the COVID-19 pandemic. The role of The Medicines Patent Pool

Global Health with Greg Martin

USP COVID-Connect | Sustaining access to quality medicines through Patent Pooling

US Pharmacopeia

Access to Oncology Medicines Coalition - The Medicines Patent Pool

How the Medicines Patent Pool can help to overcome patent-related constraints on new ARVs to ...

IAC - the International AIDS Conference

In conversation with Charles Gore: What does the Medicines Patent Pool do?

MedicinesPatentPool

The People’s Vaccine: IP, Access to Medicines, and the Coronavirus COVID-19 - Prof. Matthew Rimmer

The People's Vaccine: Intellectual Property and Access to Medicines in the Age of COVID-19

COVID19 Pandemic: Intellectual Property Management for Access to Diagnostics, Medicines and Vaccines

SouthCentre GVA

Revisiting the Access to Medicine Debates in the COVID-19 Era

The MPP-Pfizer agreement: Message from the Executive Director of the Medicines Patent Pool

MedicinesPatentPool

Medicines Patent Pool Strategy Launch - Message from Tedros

MedicinesPatentPool

The Medicines Patent Pool - How it works

Public health licensing to increase access and facilitate innovation: the MPP model

MedicinesPatentPool

Access to Covid-19 Vaccines, Medicines and Diagnostics: Voluntary & Compulsory Licenses TRIPS Waiver

SouthCentre GVA

Profiting from the Pandemic: Will Pharmaceutical Giants Use Patents to Limit Access to COVID Drugs?

Medicines Patent Pool (MPP) strategy for 2023-2025. Innovative public health at its best!

Global Health with Greg Martin

Working Together for Better Treatment Options

MedicinesPatentPool

FAQs: Access to medication during the pandemic

Canadian Lung Association

The COVID-19 Technology Access Pool

World Health Organization (WHO)

Overview of the MedsPaL Database by Amina Maillard, Medicines Patent Pool